DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma.

Xu-Sheng LiuLing-Ling YuanYan GaoXing MingYao-Hua ZhangYu ZhangZi-Yue LiuYi YangZhi-Jun Pei

Published in: Journal of translational medicine (2023)

F-FDG PET/CT, which can improve LUAD diagnosis accuracy. DARS2 may be a useful biomarker to diagnose, prognosis, and target treatment of LUAD patients.

Keyphrases

pet ct
end stage renal disease
ejection fraction
chronic kidney disease
positron emission tomography
prognostic factors
transcription factor
patient reported outcomes
combination therapy
replacement therapy